Alzheimer Disease Clinical Trial
— SAGE-LEAFOfficial title:
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
Verified date | August 2023 |
Source | BrightOutcome |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of the proposed study, is to adapt a positive emotion intervention for Alzheimer's Disease (AD) caregivers into a self-guided online format that incorporates social connection components and adaptive system feedback mechanisms to promote intervention adherence. Previous tests of the facilitated version of the program, called SAGE-LEAF (Social Augmentation to self-Guided Electronic delivery of the Life Enhancing Activities for Family caregivers), have shown efficacy for improving well-being in dementia caregivers. If effective, the SAGE-LEAF program can be disseminated to Alzheimer's caregivers nationwide through AD treatment and research centers.
Status | Completed |
Enrollment | 15 |
Est. completion date | April 30, 2022 |
Est. primary completion date | April 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: - Adults age 18 and over who identify as the primary caregiver of a family member with Alzheimer's Disease - Co-reside with the family caregiver - Speak and read English - Have internet access and a reliable email address Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
United States | Northwestern University | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
BrightOutcome | Northwestern University |
United States,
Kwok I, Lattie EG, Yang D, Summers A, Grote V, Cotten P, Moskowitz JT. Acceptability and Feasibility of a Socially Enhanced, Self-Guided, Positive Emotion Regulation Intervention for Caregivers of Individuals With Dementia: Pilot Intervention Study. JMIR Aging. 2023 Sep 6;6:e46269. doi: 10.2196/46269. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of Skill Pages in SAGE-LEAF Accessed by a Participant | This is to measure adherence to SAGE-LEAF intervention. Score range: 0-100%. A higher percentage means better adherence to the SAGE-LEAF intervention. | Post-study (week 6) | |
Primary | Willingness to Recommend SAGE-LEAF to Other AD Caregivers | This is to measure the acceptability of SAGE-LEAF. Score range: 1-10. A higher score indicates higher acceptability. | Post-study (week 6) | |
Primary | System Usability Scale | This is to measure the usability of SAGE-LEAF. Score range: 0-100. A higher score indicates better usability. | Post-study (week 6) | |
Secondary | Zarit Burden Interview | Measuring caregiving burden. Score range: 0-88. Higher scores indicate greater burden. | Pre-study and post-study (week 6) | |
Secondary | Oberst Caregiving Burden Scale - Time | Measuring caregiving burden in terms of time. Score range: 1-5. Higher scores indicate higher levels of caregiver burden. | Pre-study and post-study (week 6) | |
Secondary | Oberst Caregiving Burden Scale - Difficulty | Measuring caregiving burden in terms of difficulty. Score range: 1-5. Higher scores indicate higher levels of caregiver burden. | Pre-study and post-study (week 6) | |
Secondary | Positive Aspects of Caregiving Scale | Measuring positive aspects to caregiving for dementia patients. Score range: 5-45. Higher scores indicate better caregivers' outlook on life and self-affirmations. | Pre-study and post-study (week 6) | |
Secondary | Role Captivity Sub-scale of Caregiver Reaction Assessment | Measuring role captivity in caregiving. Score 1-4. Higher scores indicate stronger feelings of role captivity. | Pre-study and post-study (week 6) | |
Secondary | Overload Sub-scale of Caregiver Reaction Assessment | Measuring the feeling of overload in caregiving. Score 1-4. Higher scores indicate stronger feelings of overload. | Pre-study and post-study (week 6) | |
Secondary | Caregiving Mastery Subscale of the Caregiving Appraisal Measure | Measuring caregiving mastery. Score range: 1-5. Higher scores indicate better caregiving mastery. | Pre-study and post-study (week 6) | |
Secondary | Cohen's Perceived Stress Scale | Measuring perceived stress. Score range: 0-40. Higher scores indicate higher levels of perceived stress | Pre-study and post-study (week 6) | |
Secondary | Positive Affect in Differential Emotions Scale | Measuring positive emotions. Score range: 1-5. Higher scores indicate higher levels of positive emotions. | Pre-study and post-study (week 6) | |
Secondary | Negative Affect in Differential Emotions Scale | Measuring positive emotions. Score range: 1-5. Higher scores indicate higher levels of negative emotions. | Pre-study and post-study (week 6) | |
Secondary | Patient-Reported Outcomes Measurement Information System - Depression | Measuring depression level. Score range: 20-80. Higher scores indicate higher depression levels. | Pre-study and post-study (week 6) | |
Secondary | Patient-Reported Outcomes Measurement Information System - Anxiety | Measuring anxiety level. Score range: 20-80. Higher scores indicate higher anxiety levels. | Pre-study and post-study (week 6) | |
Secondary | Patient-Reported Outcomes Measurement Information System - Sleep Disturbance | Measuring sleep disturbance level. Score range: 20-80. Higher scores indicate higher levels of sleep disturbance. | Pre-study and post-study (week 6) | |
Secondary | Patient-Reported Outcomes Measurement Information System - Meaning and Purpose | Measuring one's sense of life having purpose and that there are good reasons for living. Score range: 20-80. Higher scores indicate hopefulness, optimism, goal-directedness, and feelings that one's life is worthy. | Pre-study and post-study (week 6) | |
Secondary | Patient-Reported Outcomes Measurement Information System - Social Isolation | Measuring perceptions of being avoided, excluded, detached, disconnected from, or unknown by, others. Score range: 20-80. Higher scores indicate higher levels of perception of social isolation. | Pre-study and post-study (week 6) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Not yet recruiting |
NCT03208491 -
AZ@GAME-Eco: Economic Assessment of Serious Games for the Management of Alzheimer's Disease and Related Disorders
|
N/A |